BHS – General Annual Meeting 2017
9 – 11 Feb 2016 | Brussels, Belgium
The 32nd General Annual Meeting of the BHS will take place again in Dolce La Hulpe. The board has arranged for a high-level scientific program which covers different hematology sub-specialties. The scientific presentations will cover new developments and current recommendations for treatment of hematological diseases, but also their diagnosis approach. Based on the success of the presentation « Cost of cancer treatments » last year, we decided to prolong this experience by creating an Ethics and Economy session that will bring up this year the topic of biosimilars. Another new session « Advances in laboratory technology» has been introduced with two presentations: the first one on minimal residual disease and the second one on next-generation sequencing. The research is once again brought to the forefront with among others the selected oral presenta-tions, the commented poster walk and the awards for young researchers. On Thursday February 9th, there will be two events. The first one approaches an important mission of the BHS: the aid to patient organizations. After last year’s successful meeting, we are pleased to welcome anew the patient committees for interactive sessions. The second one is the reintroduction of the committees meeting. This will be a great opportunity to discover the committees activities but most importantly to benefit from their experience and promote interaction in the hematological community. For several years the “Nurse symposium” has become a must of our meeting and it is with great enthusiasm that we will welcome them once again. We encourage all colleagues to join us and discover this exciting program!